Retrophin Inc (NASDAQ:RTRX)

28.18
Delayed Data
As of May 18
 +0.91 / +3.34%
Today’s Change
15.55
Today|||52-Week Range
28.35
+33.74%
Year-to-Date

Today’s Trading

Previous close27.27
Today’s open27.27
Day’s range26.82 - 28.35
Volume435,515
Average volume (3 months)320,604
Market cap$1.1B
Data as of 4:00pm ET, 05/18/2018

Growth & Valuation

Earnings growth (last year)-19.38%
Earnings growth (this year)-215.38%
Earnings growth (next 5 years)+137.00%
Revenue growth (last year)+15.98%
P/E ratioNM
Price/Sales5.27
Price/Book3.59

Competitors

 Today’s
change
Today’s
% change
FPRXFive Prime Therapeut...-0.26-1.38%
EDITEditas Medicine Inc-3.13-8.24%
EPZMEpizyme Inc+0.05+0.29%
----
Data as of 4:15pm ET, 05/18/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$154.9M
Annual profit (last year)-$59.7M
Net profit margin-38.55%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen J. Aselage
Chief Operating Officer
Neil F. McFarlane
Corporate headquarters
San Diego, California

Forecasts